Medicaid Coverage and Reimbursement of Antiobesity Medications across States – Healthcare Economist
Medicaid policies vary from state-to-state. With the advent of new, GLP-1 medications (and others) to treat obesity and overweight, there […]
Medicaid policies vary from state-to-state. With the advent of new, GLP-1 medications (and others) to treat obesity and overweight, there […]
Perhaps so according to the health policy editor at the Guardian. He writes that as NHS has grown weaker, private medical insurance is becoming a […]
By KIM BELLARD Nice try, Wendy’s. During an earnings call last month, President and CEO Kirk Tanner outlined the company’s plan to try a new […]
Patient preferences should be the most important part of health care decisionmaking. However, third parties often make decisions for patients. Physicians make decisions for patients […]
Hydery and Reddy (2024) provide a nice primer on drug formularies. Below is a quick overview. What is a formulary? […]
Perhaps more education is needed. That is the conclusion from a paper by Giovatto et al. (2024). The authors conducted […]
By KMI BELLARD I’m thinking about electric vehicles (EVs)…and healthcare. Now, mind you, I don’t own an EV. I’m not seriously thinking about getting one […]
Illnesses impact not only the patients, but oftentimes impact caregivers and family members as well. However, most economic analyses do […]
By MATTHEW HOLT In recent days and weeks, there have been three stories that have really brought home to me the inanity of how we […]
A great paper by Gruber et al. 2023 looks at the evolution of long-term care for ten countries: Canada, Denmark, […]